| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.92▼ | 0.92▼ | 0.94▼ | 1.01▼ | 1.25▼ |
| MA10 | 0.96▼ | 0.96▼ | 0.99▼ | 1.08▼ | 1.59▼ |
| MA20 | 1.01▼ | 1.02▼ | 1.05▼ | 1.28▼ | 1.90▼ |
| MA50 | 1.07▼ | 1.09▼ | 1.11▼ | 1.69▼ | 2.71▼ |
| MA100 | 1.11▼ | 1.16▼ | 1.31▼ | 1.95▼ | 2.14▼ |
| MA200 | 1.19▼ | 1.45▼ | 1.69▼ | 2.17▼ | 27.40▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.011▼ | -0.010▼ | -0.014▼ | -0.014▼ | -0.088▼ |
| RSI | 21.435▼ | 22.853▼ | 20.954▼ | 20.711▼ | 29.333▼ |
| STOCH | 13.895▼ | 12.847▼ | 8.135▼ | 9.911▼ | 9.113▼ |
| WILL %R | -88.650▼ | -88.979▼ | -90.839▼ | -92.941▼ | -97.270▼ |
| CCI | -77.882 | -77.876 | -116.490▼ | -146.168▼ | -137.655▼ |
|
Tuesday, December 23, 2025 04:00 PM
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products ...
|
|
Monday, March 31, 2025 05:00 AM
SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for ...
|
|
Tuesday, December 03, 2024 11:59 PM
SAN DIEGO, CA / ACCESSWIRE / December 4, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/12/25 | 0.9089 | 0.9299 | 0.9089 | 0.9116 | 79,604 |
| 30/12/25 | 0.98 | 1.00 | 0.86 | 0.925 | 317,200 |
| 29/12/25 | 1.07 | 1.09 | 0.99 | 1.01 | 204,100 |
| 26/12/25 | 1.09 | 1.14 | 1.08 | 1.10 | 61,200 |
| 24/12/25 | 1.12 | 1.13 | 1.08 | 1.11 | 28,700 |
| 23/12/25 | 1.13 | 1.145 | 1.105 | 1.12 | 82,200 |
| 22/12/25 | 1.16 | 1.24 | 1.15 | 1.18 | 89,500 |
| 19/12/25 | 1.17 | 1.19 | 1.14 | 1.16 | 71,200 |
| 18/12/25 | 1.12 | 1.213 | 1.081 | 1.14 | 109,500 |
| 17/12/25 | 1.17 | 1.189 | 1.11 | 1.13 | 149,400 |
|
|
||||
|
|
||||
|
|